Portland-area biotech receives $100M investment led by Eli Lilly
Summary
A Portland-area biotech has secured a $100 million investment led by Eli Lilly. The news points to fresh capital flowing into life sciences innovation rather than a product release or corporate transaction. This kind of funding can support further development, expansion, and partnership activity. It also signals continued investor interest in biotech-related software and data-driven tools.
Funding
Amount
$100.0M
Total raised
Date
June 24, 2026
Announcement date
Investors
Eli Lilly and
Lead investors
Company
absci.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected